Beyond the informal market, Colombia has built a regulated, export-oriented medical and scientific cannabis sector that positions it among notable global producers. Licensed farms operate under national licensing and trade controls, growing for export to markets that have included Brazil, Australia, and Germany.
Industry reporting has put Colombia’s medical cannabis product exports at roughly $10.8 million in 2023, up from about $9.7 million in 2022, with Brazil a leading destination. These figures come from industry reporting rather than a confirmed government dataset, so they should be treated as industry estimates rather than government-verified totals; the original government trade data (for example, from DANE, DIAN, or MinCIT) would be the authoritative source.
Colombia’s advantages include equatorial growing conditions, lower land and labor costs than North American or European competitors, and a licensing framework that authorized export of dried cannabis flower for medical use. Earlier think-tank projections of much larger export revenues were aspirational and have not matched actual reported figures, so they should be read as long-term potential rather than current reality.
Full recreational legalization has been debated in Colombia’s legislature and remains an open political question. Until any such framework is enacted, Medellín sits in a layered position: a regulated medical and scientific industry alongside an openly tolerated informal culture.